🚀 Want to stay updated with the latest from #EHJCVI and #EHJIMP? 📷 Follow our amazing Social Media Editors! 📷@EHJCVIEiC & @EHJIMPEiC, our Editors-in-Chief bringing the latest to your feed!

#EHJCVI 🧬 Should Lp(a) be considered a biomarker of bioprosthetic valve vulnerability? Elevated Lp(a) emerges as an independent predictor of structural valve degeneration, particularly in stenotic/mixed phenotypes 🫀🔍 👉 Read more: https://t.co/FrKIN17tdD

📢 New Image Focus #EHJCVI A rare incidental finding of liver herniation into the pericardium 🫀 https://t.co/T4EC4aP2dG Very proud of this young promising CV imager @inesmarodrigues👸🏻 who I was happy to mentor in her first #echofirst 👣👣 #EACVI #HIT @EHJCVIEiC @EACVIPresident

#EHJCVI How useful is EAT quantification for risk stratification in asymptomatic pts? 🔍 An opportunistic strategy during lung cancer screening shows that:📉 2-year EAT changes are more strongly associated with all-cause mortality in women ❤️‍🔥 And only linked to CV mortality in

#EHJCVI 🌡️ What is the link between stress and PCAT attenuation? ↑ Attenuation is associated with ↑ IL-6, ↑ TNF-α, and ↑ plaque volume, though not with vulnerable plaque features or coronary stenosis. Chronic stress may shape these relationships🫀 👉 https://t.co/t7hqoQMMOC

#EHJCVI 🫀 Can CMR help detect cardiac allograft vasculopathy? Myocardial perfusion reserve offers high sensitivity and a high negative predictive value, with a suggested cut-off of 2.2 for ruling out disease 🔍 👉 Read more: https://t.co/gtlTR9oZSz #whyCMR

#EHJCVI 🫀 What are the effects of disopyramide and mavacamten on myocardial mechanics? Only mavacamten reduced LV mechanical dispersion and GWW, while improving GWE in obstructive HCM. LVMD <72 ms at follow-up is useful to predict VT or SCA ⚡ https://t.co/Xy2MBUE8gV

We introduced RV hemisphericity and hemiconicity to capture global RV shape. HFrEF & A-STR show a more spherical RV, while PH & TOF show a more conical. In A-STR, greater conicity predicts worse outcomes. https://t.co/GzOr65p4uF @denisamuraru @lpbadano @JSlivnickMD @EHJCVIEiC

#EHJCVI 🫀 What is the prognostic value of RVol/LAV in ventricular functional MR undergoing M-TEER? Lower RVol/LAV is linked to a higher risk of heart failure hospitalization (HR 1.25) and serves as an independent predictor 📊⚠️ 👉 Read more: https://t.co/nIK4pBUPzn #CVImaging

#EHJCVI 🩻 What predicts persistent LAA patency after closure on CCTA? 💡 At 45 days, having two factors: side-gap leak prox area >37.7 mm², radial diameter >3 mm, or angle >39.4° — predicted persistence with 94% sens and 70% spec 🫀 👉 Read more: https://t.co/FfTktjQU4O

#EHJCVI 🤖 Can #whyCMR improve prognostic assessment in AL cardiac amyloidosis? DL analysis of LGE distinguishes patients within the same Mayo stage but with different outcomes, capturing prognostic features beyond amyloid-affected areas 🫀✨ 👉 Read more: https://t.co/MbWkHxTucO

#EHJCVI 🏃‍♂️ Dilated athlete’s heart or mild dilated cardiomyopathy? CMR reveals that septal fibrosis is rare in athletes, who show lower native T1 and ECV, but higher RVEDVi and MBP, with an AUC ≈ 0.85 for ECV 🫀📊 👉 Read more: https://t.co/xXHwfAp7gT #CVImaging #whyCMR

New EACVI consensus on multimodality imaging in hypertrophic cardiomyopathy! Discover insights on sex differences, athlete’s heart, pregnancy phenotype, and key imaging recommendations across modalities 🧠👉 https://t.co/HzsFC0DbHu #EHJCVI @EACVIPresident #CVImaging #EchoFirst

#EHJCVI 🫀 How does thin-cap fibroatheroma affect non-culprit lesions? Patients with DM show more of these plaques and face higher risks of NCL-MACE after AMI, but long-term prognosis worsens in both DM and non-DM patients ⚠️🔍 👉 Read more: https://t.co/kQ6JbFMrYK #CVImaging

#EHJCVI 🫀 Long-axis shortening or GLS in CMR? A UK Biobank study shows that longitudinal shortening provides a similar predictive value for cardiovascular outcomes, with a hazard ratio of 0.78 for incident heart failure 📊💡 👉 Read more: https://t.co/3ODv94xVBS #whyCMR

#EHJCVI 📈 What is the impact of long-term adiposity in early adulthood? Higher body roundness index is associated with a greater risk of coronary artery calcium over 25 years (OR 2.59) and increased all-cause mortality 🫀⚠️ Read more 👉 https://t.co/PieRgoViU6 #CVImaging

#EHJCVI 🫀 What are the differences between current diastolic dysfunction guidelines? 📖 This editorial by @jgrapsa, @argulian, @OttoSmiseth reviews key differences and their impact 👉 Read more: https://t.co/Fqtga2S94w #EchoFirst #CVImaging #Echocardiography

#EHJCVI When should we use #EchoFirst in cardiovascular emergencies and critical care? The new EACVI–ACVC consensus highlights its key role in cardiogenic shock, AMI, ADHF, and more 🚨🫀📘 👉 Read more: https://t.co/vdLetdKIpX @EACVIPresident @ACVCPresident

#EHJCVI 🫀 Is stage 3–4 #CardiacDamage an independent #Prognostic factor for patients undergoing #TAVI? 🔍 Discover the findings and clinical implications in the full article by Carter-Storch et al.: https://t.co/GpkHPUby2C @JGrapsa @EHJCVIEiC @alessia_gimelli @pabloplopez_

Congenital left pericardial agenesis with pulmonary vein stenosis: multimodality imaging insights by @EHJCVIEiC 👉 https://t.co/WEiXN31xdu 39M with chest pain. CT: absent left pericardium → LV shift & L inf. PV stenosis (“Snoopy Nose Sign”). Conservative care; well at 3 mo.

Just published in @EHJCVIEiC: in this large cohort of HCM patients, borderzone late gadolinium enhancement was strongly associated with incident ventricular arrhythmia ⚡️🫀🧲 @pabloplopez_ @EHJIMPEiC @EACVIPresident @hvanspall @DrGEMandoli @BenekiEirini https://t.co/it3Vpg3AwD